BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 33621058)

  • 1. Novel pH-Triggered Doxorubicin-Releasing Nanoparticles Self-Assembled by Functionalized β-Cyclodextrin and Amphiphilic Phthalocyanine for Anticancer Therapy.
    Zheng K; Liu X; Liu H; Dong D; Li L; Jiang L; Huang M; Ding C
    ACS Appl Mater Interfaces; 2021 Mar; 13(9):10674-10688. PubMed ID: 33621058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymeric micelles encapsulating pH-responsive doxorubicin prodrug and glutathione-activated zinc(II) phthalocyanine for combined chemotherapy and photodynamic therapy.
    Gao D; Lo PC
    J Control Release; 2018 Jul; 282():46-61. PubMed ID: 29673646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel pH-sensitive zinc phthalocyanine assembled with albumin for tumor targeting and treatment.
    Wang Y; Zheng K; Xuan G; Huang M; Xue J
    Int J Nanomedicine; 2018; 13():7681-7695. PubMed ID: 30538452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
    He Y; Su Z; Xue L; Xu H; Zhang C
    J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Core-Interlayer-Shell DOX/ZnPc Co-loaded MSNs@ pH-Sensitive CaP@PEGylated Liposome for Enhanced Synergetic Chemo-Photodynamic Therapy.
    Ma J; Wu H; Li Y; Liu Z; Liu G; Guo Y; Hou Z; Zhao Q; Chen D; Zhu X
    Pharm Res; 2018 Feb; 35(3):57. PubMed ID: 29423532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encapsulating pH-Responsive Doxorubicin-Phthalocyanine Conjugates in Mesoporous Silica Nanoparticles for Combined Photodynamic Therapy and Controlled Chemotherapy.
    Wong RCH; Ng DKP; Fong WP; Lo PC
    Chemistry; 2017 Nov; 23(65):16505-16515. PubMed ID: 28771861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor pH-triggered "charge conversion" nanocarriers with on-demand drug release for precise cancer therapy.
    Ma BA; Sun CY
    J Mater Chem B; 2020 Oct; 8(40):9351-9361. PubMed ID: 32996552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced photo/chemo combination efficiency against bladder tumor by encapsulation of DOX and ZnPC into in situ-formed thermosensitive polymer hydrogel.
    Huang Z; Xiao H; Lu X; Yan W; Ji Z
    Int J Nanomedicine; 2018; 13():7623-7631. PubMed ID: 30538447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multifunctional nano-delivery system enhances the chemo-
    Zhao R; Ning X; Wang M; Yu A; Wang Y
    J Mater Chem B; 2021 Nov; 9(44):9174-9182. PubMed ID: 34698329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic anticancer activity of photo- and chemoresponsive nanoformulation based on polylysine-functionalized graphene.
    Wu C; He Q; Zhu A; Li D; Xu M; Yang H; Liu Y
    ACS Appl Mater Interfaces; 2014 Dec; 6(23):21615-23. PubMed ID: 25370358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable core-shell nanoassemblies for the delivery of docetaxel and Zn(II)-phthalocyanine inspired by combination therapy for cancer.
    Conte C; Ungaro F; Maglio G; Tirino P; Siracusano G; Sciortino MT; Leone N; Palma G; Barbieri A; Arra C; Mazzaglia A; Quaglia F
    J Control Release; 2013 Apr; 167(1):40-52. PubMed ID: 23298613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photo-triggered release of doxorubicin from liposomes formulated by amphiphilic phthalocyanines for combination therapy to enhance antitumor efficacy.
    Zheng K; Liu H; Liu X; Jiang L; Li L; Wu X; Guo N; Ding C; Huang M
    J Mater Chem B; 2020 Sep; 8(35):8022-8036. PubMed ID: 32766661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclodextrin Polymers as Delivery Systems for Targeted Anti-Cancer Chemotherapy.
    Bognanni N; Viale M; Distefano A; Tosto R; Bertola N; Loiacono F; Ponassi M; Spinelli D; Pappalardo G; Vecchio G
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Programmed pH/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo.
    Chen WL; Yang SD; Li F; Qu CX; Liu Y; Wang Y; Wang DD; Zhang XN
    Acta Biomater; 2018 Nov; 81():219-230. PubMed ID: 30267887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of mitochondriotropic doxorubicin derivatives using self-assembling hyaluronic acid nanocarriers in doxorubicin-resistant breast cancer.
    Liu HN; Guo NN; Guo WW; Huang-Fu MY; Vakili MR; Chen JJ; Xu WH; Wei QC; Han M; Lavasanifar A; Gao JQ
    Acta Pharmacol Sin; 2018 Oct; 39(10):1681-1692. PubMed ID: 29849132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional pH-disintegrable micellar nanoparticles of asymmetrically functionalized β-cyclodextrin-based star copolymer covalently conjugated with doxorubicin and DOTA-Gd moieties.
    Liu T; Li X; Qian Y; Hu X; Liu S
    Biomaterials; 2012 Mar; 33(8):2521-31. PubMed ID: 22204981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of β-cyclodextrin-PEG-G molecules to delay tumor growth and application of β-cyclodextrin-PEG-G aggregates as drug carrier.
    Li J; Xin M; Huo Y; Cai A; Yan M; Wang C; Wei G
    Carbohydr Polym; 2020 Feb; 229():115478. PubMed ID: 31826440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-Responsive and ROS-Augmented Nanoplatform for Chemo/Photodynamic/Chemodynamic Combination Therapy of Triple Negative Breast Cancer.
    Chen M; Yang J; Zhou L; Hu X; Wang C; Chai K; Li R; Feng L; Sun Y; Dong C; Shi S
    ACS Appl Mater Interfaces; 2022 Jan; 14(1):57-68. PubMed ID: 34935343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of PEG-PDLLA polymeric nanovesicles loaded with doxorubicin and hematoporphyrin monomethyl ether on human hepatocellular carcinoma HepG2 cells in vitro.
    Xiang GH; Hong GB; Wang Y; Cheng D; Zhou JX; Shuai XT
    Int J Nanomedicine; 2013; 8():4613-22. PubMed ID: 24324333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phthalocyanine-Conjugated Glyconanoparticles for Chemo-photodynamic Combination Therapy.
    Dag A; Cakilkaya E; Omurtag Ozgen PS; Atasoy S; Yigit Erdem G; Cetin B; Çavuş Kokuroǧlu A; Gürek AG
    Biomacromolecules; 2021 Apr; 22(4):1555-1567. PubMed ID: 33793222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.